A. Price

Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome.

J. Davis, L. Parton, E. Flaster, 1996, Pediatrics.

Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome.

W. Carlo, J. Davis, A. Spitzer, 1997, Pediatrics.

Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.

J. Davis, R. Parad, E. Allred, 2003, Pediatrics.

Birth With Recombinant Human CuZn Superoxide Dismutase Pulmonary Outcome at 1 Year Corrected Age in Premature Infants Treated at

J. Davis, R. Parad, E. Allred, 2006 .